Corebridge Financial’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-60,898
| Closed | -$828K | – | 786 |
|
|
2025
Q1 | $828K | Sell |
60,898
-902
| -1% | -$12.3K | ﹤0.01% | 1349 |
|
|
2024
Q4 | $1.26M | Sell |
61,800
-4,665
| -7% | -$95.1K | 0.01% | 1227 |
|
|
2024
Q3 | $1.94M | Sell |
66,465
-410
| -0.6% | -$11.9K | 0.01% | 1055 |
|
|
2024
Q2 | $1.55M | Buy |
+66,875
| New | +$1.55M | 0.01% | 1104 |
|